BlackRock Japan’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$18K Buy
3,634
+2,932
+418% +$87K ﹤0.01% 1148
2016
Q3
$32K Buy
702
+131
+23% +$7.39K ﹤0.01% 1045
2016
Q2
$29K Sell
571
-70
-11% -$3.48K ﹤0.01% 1093
2016
Q1
$27K Buy
641
+426
+198% +$21.7K ﹤0.01% 1145
2015
Q4
$17K Buy
215
+144
+203% +$8.33K ﹤0.01% 1193
2015
Q3
$3K Sell
71
-709
-91% -$37.6K ﹤0.01% 1238
2015
Q2
$41K Buy
+780
New +$38.8K ﹤0.01% 1107
2014
Q2
– Sell
-6,912
Closed -$247K – 1426
2014
Q1
$247K Buy
6,912
+1,958
+40% +$66K ﹤0.01% 896
2013
Q4
$160K Buy
+4,954
New +$147K ﹤0.01% 946

Other funds holding ISEE

BlackRock Japan's ISEE Position: Q4 2016 in Review

BlackRock Japan increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 418% in Q4 2016, buying an estimated $87K and bringing the position to 3,634 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #1148.

BlackRock Japan first reported a position in ISEE in Q4 2013 and has held it in 9 quarters since. The position peaked at $247K in Q1 2014. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • BlackRock Japan held 3,634 shares of IVERIC bio, Inc. Common Stock worth $18K as of Q4 2016.
  • BlackRock Japan bought 2,932 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $87K.
  • IVERIC bio, Inc. Common Stock made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1148 holding.
  • BlackRock Japan first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and has held it in 9 quarters since.
  • BlackRock Japan's IVERIC bio, Inc. Common Stock position peaked at $247K in Q1 2014.
  • 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.